Company Overview

Dai-ichi Karkaria Limited (CIN: L24100MH1960PLC011681) is a specialty chemicals manufacturing company with manufacturing facilities at Dahej, Gujarat and Kurkumbh, Pune. The company operates in Oilfield Chemicals, Home & Personal Care, Paints & Coatings, Textile Auxiliaries, and Agrochemicals segments.

Financial Performance FY 2025-26

Consolidated Results: Revenue from operations declined to ₹16,130 lakhs (₹161.30 crores) from ₹18,138 lakhs in previous year. The company reported a net loss of ₹74 lakhs after accounting for ₹20 lakh exceptional item related to one-time impact of New Labour Code. Earnings per share stood at (₹0.99) per share of ₹10 each.

Standalone Performance: Total income was ₹168.65 lakhs with net loss of ₹0.54 lakhs, compared to net profit of ₹6.18 lakhs in previous year. Book value per share was ₹217.60.

Balance Sheet: Total consolidated assets stood at ₹22,404 lakhs with equity share capital of ₹745 lakhs (74,51,229 shares). Current borrowings were ₹1,300 lakhs and trade payables at ₹1,806 lakhs. Contingent liabilities totaled ₹1,764 lakhs including disputed tax demands and guarantees.

66th Annual General Meeting

Date & Time: August 27, 2026 at 11:30 AM IST through Video Conferencing

Record Date: August 20, 2026 for dividend entitlement

Key Agenda Items:

  • Adoption of audited standalone and consolidated financial statements
  • Declaration of dividend of ₹1.50 per equity share (15%) for FY 2025-26
  • Re-appointment of Mrs. Shernaz Vakil as Director
  • Approval of Material Related Party Transactions: ₹60 crores with ChampionX Dai-ichi India Private Limited and ₹60 crores with Indian Oxides and Chemicals Private Limited

Operational Developments

The company commissioned a new EO reactor at Dahej facility for ethoxylation capacity expansion and established a dedicated Agrochemical Application Laboratory. Achieved zero fatalities and zero lost time incidents across all manufacturing locations.

Audit & Compliance

Auditors B S R & Co. LLP issued an unmodified opinion confirming that the company and its subsidiary have adequate internal financial controls operating effectively as of March 31, 2026. The audit was conducted in accordance with Guidance Note issued by ICAI and Standards on Auditing.

Related Party Transactions

With ChampionX Dai-ichi India Private Limited (50:50 JV): FY 2025-26 transactions totaled ₹25.94 crores (Sales: ₹25.79 crores). CXDI reported FY25-26 turnover of ₹58.05 crores and PAT of ₹4.95 crores.

With Indian Oxides and Chemicals Private Limited: FY 2025-26 purchases totaled ₹8.75 crores. IOCL reported FY25-26 turnover of ₹397.14 crores with net loss of ₹0.44 crores.

Corporate Governance & Shareholding

Board composition includes 6 Directors (2 Executive, 4 Non-Executive including 3 Independent). Promoters hold 63.98% (47,67,296 shares) while public holding is 36.02%. Dematerialized holdings represent 99.05% of total shares.

Dividend Information

Dividend of ₹1.50 per share recommended, totaling ₹111.77 lakhs on standalone basis and ₹261 lakhs consolidated. Payment to be made within 7 days of AGM approval with August 20, 2026 as record date.

Credit Rating History

CRISIL upgraded ratings to CRISIL BBB-/Stable (Long-term) and CRISIL A3 (Short-term) on July 22, 2025, but subsequently downgraded to CRISIL BB+/Stable and CRISIL A4+ on March 4, 2026. Ratings were voluntarily withdrawn effective April 14, 2026.